Investigative Trial of Interferon Alpha-2b To Shrink Cancer of the Eye
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore whether the drug pegylated-interferon-alfa-2b
(PEG-IFN) has any effect on a certain type of immune cell (called natural killer cells) in
patients with eye melanoma.